| 2-yr primary TKA | 5-yr primary TKA | 2-yr revision TKA | 5-yr revision TKA | ||||
---|---|---|---|---|---|---|---|---|
 | Events for non-responders (3818/ 10957) | OR (95%)) CI) | Events for non-responders (3170/7404) | OR (95%)) CI) | Events for non-responders (1162/2695) | OR (95%)) CI) | Events for non-responders (961/1842) | OR (95%)) CI) |
Gender | Â | Â | Â | Â | Â | Â | Â | Â |
 Women | 2184/6161 (35.4%) |  | 1860/4191 (44.4%) |  | 621/1402 (44.3%) |  | 509/944 (53.9%) |  |
 Men | 1634/4796 (34.1%) | 0.94 (0.86,1.03) | 1310/3213 (40.8%) | 0.86 ‡ (0.78,0.96) | 541/1293 (41.8%) | 1.10 (0.94, 1.29) | 452/898 (50.3%) | 0.87 (0.72,1.05) |
Age groups n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
 ≤60 yrs | 841/2154 (39%) |  | 728/1473 (49.4%) |  | 283/587 (48.2%) |  | 241/413 (58.4%) |  |
 >60-70 yrs | 1273/3804 (33.5%) | 0.79 ‡ (0.69,0.89) | 1065/2641 (40.3%) | 0.69 ‡ (0.60,0.80) | 365/816 (44.7%) | 0.87 (0.70,1.08) | 281/555 (50.6%) | 0.73* (0.56,0.96) |
 >70-80 yrs | 1387/4121 (33.7%) | 0.79 ‡ (0.70,0.89) | 1142/2759 (41.4%) | 0.72 ‡ (0.63,0.83) | 391/1034 (37.8%) | 0.65‡ (0.53,0.81) | 350/714 (49%) | 0.69 ‡ (0.53,0.89) |
 >80 yrs | 317/878 (36.1%) | 0.88 (0.74,1.05) | 235/531 (44.3%) | 0.81 (0.65,1.01) | 123/258 (47.7%) | 0.98 (0.72,1.32) | 89/160 (55.6%) | 0.89 (0.61,1.31) |
BMI Categorized | Â | Â | Â | Â | Â | Â | Â | Â |
 ≤24.9 | 514/1474 (34.9%) |  | 452/1018 (44.4%) |  | 172/375 (45.9%) |  | 136/258 (52.7%) |  |
 25-29.9 | 1287/3766 (34.2%) | 0.97 (0.84,1.11) | 1061/2586 (41%) | 0.87 (0.74,1.02) | 375/925 (40.5%) | 0.80 (0.63,1.03) | 310/655 (47.3%) | 0.81 (0.60,1.09) |
 30-39.9 | 1644/4712 (34.9%) | 1.00 (0.87,1.15) | 1346/3169 (42.5%) | 0.92 (0.79,1.08) | 485/1149 (42.2%) | 0.86 (0.68,1.09) | 423/784 (54%) | 1.05 (0.79,1.41) |
 ≥40 | 355/960 (37%) | 1.10 (0.91,1.32) | 299/602 (49.7%) | 1.24 (0.99,1.55) | 123/229 (53.7%) | 1.37 (0.98,1.91) | 89/136 (65.4%) | 1.70* (1.09,2.66) |
ASA | Â | Â | Â | Â | Â | Â | Â | Â |
 1-2 | 2021/6136 (32.9%) |  | 1771/4238 (41.8%) |  | 505/1270 (39.8%) |  | 432/899 (48.1%) |  |
 3-4 | 1772/4778 (37.1%) | 1.20 ‡ (1.10,1.31) | 1388/3129 (44.4%) | 1.11* (1.00,1.23) | 651/1414 (46%) | 1.29 ‡ (1.10,1.51) | 523/933 (56.1%) | 1.38 ‡ (1.15,1.66) |
Deyo-Charlson index (5 point increase) |  | 1.30 ‡ (1.17,1.44) |  | 1.07 (0.93,1.22) |  | 1.16 (0.93,1.44) |  | 1.63 ‡ (1.21,2.20) |
Income | Â | Â | Â | Â | Â | Â | Â | Â |
 >$45 K | 1035/3099 (33.4%) |  | 720/1665 (43.2%) |  | 236/548 (43.1%) |  | 163/304 (53.6%) |  |
 ≤$35 K | 699/2098 (33.3%) | 1.00 (0.87,1.14) | 736/1841 (40%) | 0.87 (0.75,1.02) | 254/595 (42.7%) | 1.98 (0.77,1.25) | 243/488 (49.8%) | 0.86 (0.64, 1.15) |
 >$35 K-$45 K | 1347/4044 (33.3%) | 1.00 (0.89,1.11) | 1058/2541 (41.6%) | 0.94 (0.82,1.07) | 450/1050 (42.9%) | 0.99 (0.80,1.23) | 363/677 (53.6%) | 1.00 (0.76,1.32) |
Distance | Â | Â | Â | Â | Â | Â | Â | Â |
 0-100 miles | 1785/5454 (32.7%) |  | 1443/3523 (41%) |  | 390/865 (45.1%) |  | 284/571 (49.7%) |  |
 >100-500 miles | 1435/4166 (34.4%) | 1.08 (0.98,1.19) | 1218/2871 (42.4%) | 1.06 (0.95,1.19) | 602/1449 (41.5%) | 0.87 (0.72,1.03) | 535/993 (53.9%) | 1.18 (0.95, 1.46) |
 >500 miles or Non-US | 476/1017 (46.8%) | 1.81 ‡ (1.55,2.11) | 382/709 (53.9%) | 1.68 ‡ (1.40,2.03) | 129/293 (44%) | 0.96 (0.73,1.27) | 103/200 (51.5%) | 1.07 (0.77, 1.50) |
Underlying diagnoses | Â | Â | Â | Â | Â | Â | Â | Â |
 Inflammatory arthritis | 172/428 (40.2%) |  | 155/344 (45.1%) |  |  |  |  |  |
 Osteoarthritis | 3480/10190(34.2%) | 0.77* (0.62,0.97) | 2872/6794 (42.3%) | 0.89 (0.70,1.14) |  |  |  |  |
 Other | 166/338 (49.1%) | 1.44* (1.05,1.96) | 143/266 (53.8%) | 1.42* (1.00,2.01) |  |  |  |  |
 Loosening/wear or osteolysis |  |  |  |  | 584/1453 (40.2%) |  | 475/1015 (46.8%) |  |
 Dislocation, bone or prosthesis fracture, instability, non-union |  |  |  |  | 254/597 (42.5%) | 1.10 (0.91,1.34) | 216/393 (55%) | 1.39 ‡ (1.10,1.76) |
 Failed prior arthroplasty with components removed or infection |  |  |  |  | 324/645 (50.2%) | 1.50‡ (1.24,1.82) | 270/434 (62.2%) | 1.87 ‡ (1.48,2.36) |